The New York-based company, which is working with a financial adviser, could fetch more than $700 million in a sale, said the people, who asked to not be identified because the matter isn’t public. A final decision on pursuing a sale hasn’t been made and EquityZen could opt to remain independent, the people said.
A representative for EquityZen declined to comment.
Platforms such as EquityZen and
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.